Research & Therapy
Dr. Eric Garland is a clinical researcher and psychotherapist with over 15 years of experience providing mindfulness-based therapy cognitive-behavioral therapy, and clinical hypnosis. Dr. Garland has received more than $40 million in federal research grants for his groundbreaking work on the development of Mindfulness-Oriented Recovery Enhancement (M.O.R.E.), which continues to receive high praise as a evidence-based therapy for reducing addictive behavior, relieving stress, and helping people heal from physical and emotional pain.
Dr. Garland focuses on translating findings from cognitive, affective, and social neuroscience into novel interventions (mindfulness) that effectively target stress-related, biobehavior conditions such as addiction, chronic pain, and emotional deregulation.
Mindfulness-Oriented Recovery Enhancement (MORE) is a mental training program that unites complementary aspects of mindfulness training, “Third Wave” cognitive-behavior therapy, and positive psychological principles into an integrative treatment strategy.
Dr. Garland is a licensed Clinic Social Worker and Approved Consultant of the American Society for Clinical Hypnosis with over 10 years of experience offering cognitive-behavioral therapy, mindfulness-based therapy, and clinical hypnosis. His approach is pragmatic & solution-focused.
Are you currently treating your chronic pain with prescription painkillers? Receive free therapy and learn to cope with pain, manage medication, and deal with life’s challenges while participating in a chronic pain research study.
Most recent updates from Dr. Eric Garland:
- Dr. Garland Appointed to NIH HEAL Multi-disciplinary Workgroup
- Research on MORE Covered by NIDA: Prescription Opioid Misuse Treatment Leverages Mindfulness To Amplify Natural Rewards
- Mindfulness-Oriented Recovery Enhancement Basic Training Workshop on July 28-29, Salt Lake City
- Mindfulness-Based Treatment of Addiction: Current State of the Field and Envisioning the Next Wave of Research
- Research on Mindfulness-Oriented Recovery Enhancement Discussed at NIH to Address the Opioid Crisis